Dopamine is Required for Activity-Dependent Amplification of Arc mRNA in Developing Postnatal Frontal Cortex

Cereb Cortex. 2017 Jul 1;27(7):3600-3608. doi: 10.1093/cercor/bhw181.

Abstract

The activity-regulated gene Arc/Arg3.1 encodes a postsynaptic protein crucially involved in glutamatergic synaptic plasticity. Genetic mutations in Arc pathway and altered Arc expression in human frontal cortex have been associated with schizophrenia. Although Arc expression has been reported to vary with age, what mechanisms regulate Arc mRNA levels in frontal cortex during postnatal development remains unclear. Using quantitative mRNA analysis of mouse frontal cortical tissues, we mapped the developmental profiles of Arc expression and found that its mRNA levels are sharply amplified near the end of the second postnatal week, when mouse pups open their eyes for the first time after birth. Surprisingly, electrical stimulation of the frontal cortex before eye-opening is not sufficient to drive the amplification of Arc mRNA. Instead, this amplification needs both electrical stimulation and dopamine D1-type receptor (D1R) activation. Furthermore, visual stimuli-driven amplification of Arc mRNA is also dependent on D1R activation and dopamine neurons located in the ventral midbrain. These results indicate that dopamine is required to drive activity-dependent amplification of Arc mRNA in the developing postnatal frontal cortex and suggest that joint electrical and dopaminergic activation is essential to establish the normal expression pattern of a schizophrenia-associated gene during frontal cortical development.

Keywords: activity-dependent gene expression; arc; dopamine; frontal cortex; postnatal development.

Publication types

  • Research Support, N.I.H., Intramural

MeSH terms

  • AIDS-Related Complex / genetics*
  • AIDS-Related Complex / metabolism
  • Adrenergic Agents / pharmacology
  • Age Factors
  • Amphetamine / pharmacology
  • Animals
  • Animals, Newborn
  • Antioxidants / pharmacology
  • Ascorbic Acid / pharmacology
  • Benzazepines / pharmacology
  • Dopamine / metabolism*
  • Dopamine Agents / pharmacology
  • Dopaminergic Neurons / drug effects
  • Electroshock / methods
  • Frontal Lobe / growth & development*
  • Frontal Lobe / metabolism*
  • Gene Expression Regulation, Developmental / physiology*
  • Mice
  • Mice, Inbred C57BL
  • Microarray Analysis
  • Oxidopamine / pharmacology
  • RNA, Messenger / metabolism*
  • Receptors, Dopamine D1 / metabolism
  • Ventral Tegmental Area / cytology

Substances

  • Adrenergic Agents
  • Antioxidants
  • Benzazepines
  • Dopamine Agents
  • RNA, Messenger
  • Receptors, Dopamine D1
  • SCH 23390
  • Oxidopamine
  • Amphetamine
  • Ascorbic Acid
  • Dopamine
pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy